Questions have been raised about how Australia ensures the quality of its imported medicines after a major pharmaceutical ...

The US Food and Drug Administration (FDA) admonished Sun Pharmaceutical Industries in a recent warning ... These violations prompted FDA to place the firm on import alert on 7 December. FDA inspected ...

In a warning letter, the FDA has highlighted a series of lapses at Sun Pharma’s Gujarat plant, which has been put on an import alert list by the US drug regulator. In the letter dated December ...

Drug major Sun Pharmaceutical Industries on Monday said it has acquired three anti-inflammatory brands from Mumbai-based Aksigen Hospital Care. The company has acquired Disperzyme, Disperzyme-CD and ...

The Food and Drug Administration is continuing its use of import alerts to enforce U.S. food safety regulations for food from foreign countries. The agency updates and modifies the alerts as needed.

Sun Pharmaceutical, one of the world’s largest generic drugmakers, was scolded by the U.S. Food and Drug Administration for a host of serious manufacturing violations at a key plant in India ...

The Indian-based pharma company stated that it expects the deal to be completed during the first quarter of 2023.

iBeat Analytics Ibeat 1 Year HTTPS To track article's statistics The US health regulator has pulled up drug major Sun Pharma for manufacturing lapses, including failure to follow appropriate ...

An import alert may follow a warning letter or OAI classification if the FDA is not satisfied with ... subject to the exemption of certain products. Sun Pharmaceutical Industries' Halol facility ...

A Boca Raton pharmaceutical company has agreed to settle charges with the Food and Drug Administration that allege improper ...

"Sun Pharma’s immediate focus would be to follow Concert’s plan to submit a New Drug Application (NDA) to the USFDA in the ...

Sun Pharmaceutical Industries Ltd. shares inched down 0.10% to 1,039.95 Indian rupees Wednesday, on what proved to be an ...